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Dear Editor,
 
One of the themes that has arisen frequently in 
recent ENT conferences is soft palate sclerotherapy for 
the treatment of snoring and sleep disordered breathing 
(SDB); this method is a promising option for outpatient 
therapy, given its ease and low cost. Although this theme 
is discussed routinely, its naming lacks standardization. 
Our proposition is to suggest a new term in Portuguese 
for this form of treatment: “Injeção Roncoplástica” (Rhon-
choplastic Injection).
In medical practice, the term sclerotherapy is well 
established in naming the esthetic treatment of varices 
and telangiectasis; it may be used to describe numerous 
and distinct types of treatment, such as in the approach 
to thyroid cysts, hydroceles, cystic hygroma, hemangio-
mas, venous malformations, esophageal varicose veins, 
hemorrhoids, and others.
Even when this theme is discussed in papers and 
otorhinolaryngological conferences, there is no standard 
name for the use of sclerosing agents in the treatment of 
snoring, which might lead to confusion. The same theme 
has been described as: sclerotherapy for the treatment 
of snoring, injection of sclerosing substances for the tre-
atment of snoring, soft palate treatment with sclerosing 
substances, interstitial therapy for snoring, etc.
Although Straus (1943) was the first to use sclerothe-
rapy for the treatment of snoring, Brietzke and Mair were 
truly responsible for the main studies of this treament.1-3 
These authors published papers in 2001 and 2003 descri-
bing the use of Sotradecol® (sodium tetradecyl sulphate) 
injected into the human soft palate, with excellent clinical 
results for the treatment of snoring: a 75 to 92% success 
rate after a 12 to 19 month follow-up.1,2 In 2004, Brietzke 
and Mair published a comparative study using various 
types of sclerosing substances for the treatment of sno-
ring. The found that 50% ethanol was similar in efficacy 
to Sotradecol®, albeit with a slightly higher complication 
rate.3 Few papers have been published on sclerotherapy 
for the treatment of snoring to date, but those that have 
been published report favorable results.1-6
There are very few studies on this theme in Brazil. 
In 2002, Lopes et al. injected Ethamolin® (monoethano-
lamine oleate) in the base of the tongue of pigs and then 
analyzed histologically the injection sites. They found that 
collagen had become compacted and thickened and that 
fibrosis had formed much more significantly compared to 
controls.6 We are currently running a study on human soft 
palate sclerotherapy for the treatment of snoring and SDB. 
In this study we compare 50% ethanol with Ethamolin® 
injections. Partial results have been forthcoming and we 
hope to publish these findings shortly.
The term sclerotherapy is well established and 
widely disseminated for naming many different medical 
therapies, especially sclerosis of varicose veins and telan-
giectasis. Thus, our proposition is to use the term “Injeção 
Roncoplástica” (Rhonchoplastic Injection) in Portuguese 
specifically to designate the injection of sclerosing subs-
tances into the soft palate for the treatment of snoring and 
SDB. We believe that this term is more adequate, since it 
is distinct and self-explanatory, and closer to the English 
term “Injection Snoreplasty”.
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